Method of detecting androgen-regulated gene
First Claim
Patent Images
1. A polynucleotide array comprising:
- (a) a planar, non-porous solid support having at least a first surface; and
(b) a first set of polynucleotide probes attached to the first surface of the solid support, wherein the first set of polynuceotide probes comprises polynucleotide sequences derived from genes that are up-regulated or down-regulated in response to androgen.
0 Assignments
0 Petitions
Accused Products
Abstract
This invention relates to androgen-regulated nucleic acids, a polynucleotide array containing these androgen-regulated nucleic acids, and methods of using the polynucleotide array in the diagnosis and prognosis of prostate cancer.
12 Citations
24 Claims
-
1. A polynucleotide array comprising:
-
(a) a planar, non-porous solid support having at least a first surface; and
(b) a first set of polynucleotide probes attached to the first surface of the solid support, wherein the first set of polynuceotide probes comprises polynucleotide sequences derived from genes that are up-regulated or down-regulated in response to androgen. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)
-
-
18. An isolated nucleic acid molecule selected from:
-
(a) the polynucleotide sequence of SEQ ID NO;
2; and
(b) an isolated nucleic acid molecule that encodes a polypeptide having an amino acid sequence of SEQ ID NO;
3. - View Dependent Claims (19, 20, 21)
-
-
22. A method of detecting prostate cancer in a patient, comprising:
-
(a) detecting mRNA corresponding to the polynucleotide sequence of SEQ ID NO;
2 in a biological sample from the patient; and
(b) correlating the amount of mRNA corresponding to the polynucleotide sequence of SEQ ID NO;
2 in the sample with the presence of prostate cancer in the patient.
-
- 23. An isolated polypeptide, comprising the amino acid sequence of SEQ ID NO:
Specification